Advertisement

Topics

BioNeutral Laboratories Corporation Company Profile

11:59 EDT 24th September 2017 | BioPortfolio

BioNeutral was organized in 2003 to commercialize a novel combinational chemistry-based technology that can neutralize harmful environmental contaminants, toxins and dangerous micro-organisms including bacteria, viruses and spores. The Ygiene(TM) and Ogiene(TM) formulations are "Green" and include natural and common ingredients which are found in baby products and the foods we eat. These widely used compounds are combined in unique ways to create enhanced results.


News Articles [419 Associated News Articles listed on BioPortfolio]

Intrinsic4D Inc. Announces Public Sale of Substantially all of the Assets of its Operating Subsidiary and Transfer to NEX

TORONTO, ONTARIO -- (Marketwired) -- 05/11/17 -- Intrinsic4D Inc. (the "Corporation") (TSX VENTURE: IFD) provides stakeholders with an update in relation to its financial status and solvency. Publi...

Contrasting IDEXX Laboratories

IDEXX Laboratories and Heska Corporation are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, di...

Enterome to move its research laboratories

Enterome, a pioneer of innovative therapies for microbiome-related diseases announced that the Company is moving its research laboratories to Genopole, a leading biocluster dedicated to biotechnology ...

Zacks: Brokerages Anticipate Impax Laboratories Inc (IPXL) Will...

Wall Street analysts forecast that Impax Laboratories Inc will post $196.18 million in sales for the current fiscal quarter, Zacks reports. Four analysts have made estimates for Impax Laboratories'...

Analyzing Impax Laboratories

Pfizer and Impax Laboratories are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, valuation, institutional owner...

$0.14 EPS Expected for Impax Laboratories, Inc. (IPXL) This Quarter

Analysts expect Impax Laboratories, Inc. to report earnings per share of $0.14 for the current fiscal quarter, according to Zacks . Four analysts have provided estimates for Impax Laboratories' ea...

Savaria Announces Resignation of Director and Appointment of New Director

LAVAL, QUEBEC -- (Marketwired) -- 07/07/17 -- Savaria Corporation (TSX: SIS) ("Savaria" or the "Corporation"), one of North America's leaders in the accessibility industry, is pleased to announce th...

Zacks: Analysts Anticipate Impax Laboratories Inc (IPXL) to Announce $0.13 EPS

Equities analysts expect that Impax Laboratories Inc will post earnings per share of $0.13 for the current quarter, according to Zacks Investment Research . Four analysts have made estimates for Impax...

PubMed Articles [188 Associated PubMed Articles listed on BioPortfolio]

Project management: importance for diagnostic laboratories.

The constraints applied on diagnostic laboratories to improve both quality and productivity together with personal shortages incite laboratory managers to constantly optimize the laboratory workflows,...

Cancer incidence in female laboratory employees: extended follow-up of a Swedish cohort study.

Work in chemical laboratories is associated with exposure to chemicals, of which some are known or suspected carcinogens. A cohort study of laboratory workers in Stockholm followed until 1992 showed a...

This Is not Participatory Design - A Critical Analysis of Eight Living Laboratories.

Design of Health Technology for elderly and care personnel has a high priority because of a severe increase of elderly citizens in need of health care combined with a decrease of resources in the heal...

Consistency of BRCA1 and BRCA2 Variant Classifications Among Clinical Diagnostic Laboratories.

Genetic tests of the cancer predisposition genes BRCA1 and BRCA2 inform significant clinical decisions for both physicians and patients. Most uncovered variants are benign, and determining which few a...

CLSI-Based Validation of Manufacturer-Derived Reference Intervals on the Cobas 8000 Platform.

Reference intervals provided by diagnostic test manufacturers should be transferred to clinical laboratories after validation. Although protocols exist, laboratories rarely perform and report on resul...

Clinical Trials [231 Associated Clinical Trials listed on BioPortfolio]

A Comparative Clinical Trial to Evaluate the Safety and Clinical Equivalence of Clotrimazole Troche/Lozenges USP, 10mg (Unique Pharmaceutical Laboratories, India) With Clotrimazole Troche 10mg (Roxane Laboratories Inc., USA) in Subjects With Oropharyngeal

The objectives of this study are to compare the efficacy and safety of Clotrimazole troche/ lozenges USP, 10 mg (Unique Pharmaceutical Laboratories, India) vs. Clotrimazole Troche/ Lozenge...

Bioequivalence Study of Meloxicam Tablets 15 mg of Dr.Reddy's Laboratories Limited Under Fed Condition

The objective of this study is to determine the relative bioavailability of one 15 mg Meloxicam tablet (Dr. Reddy. Laboratories Ltd.,Generics) versus one 15 mg Mobic (meloxicam) Tablet (Bo...

Bioequivalence Study of Dr.Reddy's Laboratories Limited Finasteride Tablets 1 mg Under Fed Condition

The objective of this study was to compare the single-dose relative bioavailability of Dr. Reddy's Laboratories, Ltd. and Merck & Co. (Propecia®) 1 mg finasteride tablets under fed condi...

Bioequivalence Study of Meloxicam Tablets 15 mg of Dr.Reddy's Laboratories Limited Under Fasting Condition

The objective of this study is to determine the relative bioavailability of one 15 mg Meloxicam tablet (Dr. Reddy. Laboratories Ltd.,Generics) versus one 15 mg Mobic (meloxicam) Tablet (Bo...

Bioequivalence Study of Dr. Reddy's Laboratories Limited, Finasteride Tablets 1 mg Under Fasting Condition

The objective of this study was to compare the single-dose relative bioavailability of Dr. Reddy's Laboratories, Ltd. and Merck & Co. (Propecia®) 1 mg finasteride tablets under fasting c...

Companies [1103 Associated Companies listed on BioPortfolio]

BioNeutral Laboratories Corporation

BioNeutral was organized in 2003 to commercialize a novel combinational chemistry-based technology that can neutralize harmful environmental contaminants, toxins and dangerous micro-organisms incl...

BioNeutral Group, Inc.

Headquartered at the New Jersey Institute of Technology/EDC in Newark, BioNeutral Group, Inc., is a specialty technology-based life-science company which has developed a technolog...

Toshiba Corporation

Toshiba Medical Systems Corporation is a leading worldwide provider of medical diagnostic imaging systems and comprehensive medical solutions, such as CT, X-ray and vascular, ultr...

Bruker Daltonics

Bruker Corporation is a leading provider of high-performance scientific instruments and solutions for molecular and materials research, as well as for industrial and applied analy...

MP Biomedicals, LLC

MP Biomedicals is a global corporation and world leader in life sciences, fine chemicals and diagnostics products. Our product portfolio of over 55,000 products represents one of ...

More Information about "BioNeutral Laboratories Corporation" on BioPortfolio

We have published hundreds of BioNeutral Laboratories Corporation news stories on BioPortfolio along with dozens of BioNeutral Laboratories Corporation Clinical Trials and PubMed Articles about BioNeutral Laboratories Corporation for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of BioNeutral Laboratories Corporation Companies in our database. You can also find out about relevant BioNeutral Laboratories Corporation Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record